Exact Sciences
EXAS
#1179
Rank
S$24.72 B
Marketcap
S$130.19
Share price
0.04%
Change (1 day)
71.88%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2025 (TTM): -S$1.32 Billion

According to Exact Sciences's latest financial reports the company's current earnings are S$3.08 Billion. In 2024 the company made an earning of -S$1.3 Billion a decrease over its 2023 earnings that were of -S$0.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$1.32 Billion1.9%
2024 -S$1.3 Billion435.05%
2023 -S$0.25 Billion-69.18%
2022 -S$0.79 Billion-25.77%
2021 -S$1.06 Billion1.68%
2020 -S$1.04 Billion271.17%
2019 -S$0.28 Billion58.99%
2018 -S$0.18 Billion20.89%
2017 -S$0.15 Billion-30.95%
2016 -S$0.22 Billion5.09%
2015 -S$0.21 Billion57.24%
2014 -S$0.13 Billion116.53%
2013 -S$58.9 Million
2011 -S$36.67 Million143.73%
2010 -S$15.05 Million27.85%
2009 -S$11.77 Million0.27%
2008 -S$11.74 Million-20.95%
2007 -S$14.85 Million-13.53%
2006 -S$17.17 Million-10.07%
2005 -S$19.1 Million-21.81%
2004 -S$24.42 Million-33.44%
2003 -S$36.69 Million-6.51%
2002 -S$39.24 Million17.95%
2001 -S$33.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
S$11.57 B-1,038.16%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
S$31.47 M-102.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
S$83.8 M-106.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-S$0.54 Billion-56.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-S$44.49 Million-96.40%๐Ÿ‡บ๐Ÿ‡ธ USA